Quantrx Biomedical
QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of h… Read more
Quantrx Biomedical (QTXB) - Total Assets
Latest total assets as of September 2022: $5.38K USD
Based on the latest financial reports, Quantrx Biomedical (QTXB) holds total assets worth $5.38K USD as of September 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Quantrx Biomedical - Total Assets Trend (1994–2021)
This chart illustrates how Quantrx Biomedical’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Quantrx Biomedical - Asset Composition Analysis
Current Asset Composition (December 2021)
Quantrx Biomedical's total assets of $5.38K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 100.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1994–2021)
This chart illustrates how Quantrx Biomedical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Quantrx Biomedical's current assets represent 100.0% of total assets in 2021, an increase from 93.6% in 1994.
- Cash Position: Cash and equivalents constituted 100.0% of total assets in 2021, up from 83.8% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1994.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Quantrx Biomedical Competitors by Total Assets
Key competitors of Quantrx Biomedical based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Quantrx Biomedical - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Quantrx Biomedical generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Quantrx Biomedical is currently not profitable relative to its asset base.
Quantrx Biomedical - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.00 | 0.01 | 0.42 |
| Quick Ratio | 0.00 | 0.01 | 0.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-2.84 Million | $ -2.58 Million | $ -1.25 Million |
Quantrx Biomedical - Advanced Valuation Insights
This section examines the relationship between Quantrx Biomedical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 5.37 |
| Asset Growth Rate (YoY) | -89.3% |
| Total Assets | $5.95K |
| Market Capitalization | $31.97K USD |
Valuation Analysis
Premium Asset Valuation: The market values Quantrx Biomedical's assets at a significant premium ( 5.37x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Quantrx Biomedical's assets decreased by 89.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Quantrx Biomedical (1994–2021)
The table below shows the annual total assets of Quantrx Biomedical from 1994 to 2021.
| Year | Total Assets | Change |
|---|---|---|
| 2021-12-31 | $5.95K | -89.27% |
| 2020-12-31 | $55.43K | -59.64% |
| 2019-12-31 | $137.35K | -76.39% |
| 2018-12-31 | $581.79K | -58.17% |
| 2017-12-31 | $1.39 Million | +554.17% |
| 2016-12-31 | $212.61K | -40.70% |
| 2015-12-31 | $358.52K | -26.91% |
| 2014-12-31 | $490.51K | +23.26% |
| 2013-12-31 | $397.95K | -16.05% |
| 2012-12-31 | $474.03K | -19.14% |
| 2011-12-31 | $586.24K | -54.97% |
| 2010-12-31 | $1.30 Million | -3.10% |
| 2009-12-31 | $1.34 Million | -60.54% |
| 2008-12-31 | $3.40 Million | -6.74% |
| 2007-12-31 | $3.65 Million | -15.35% |
| 2006-12-31 | $4.31 Million | +226.25% |
| 2005-12-31 | $1.32 Million | +604.66% |
| 2004-12-31 | $187.60K | +102.15% |
| 2003-12-31 | $92.80K | -15.02% |
| 2002-12-31 | $109.21K | -72.00% |
| 2001-12-31 | $390.00K | -33.90% |
| 2000-12-31 | $590.00K | -56.62% |
| 1999-12-31 | $1.36 Million | -28.04% |
| 1998-12-31 | $1.89 Million | -4.06% |
| 1997-12-31 | $1.97 Million | -0.51% |
| 1996-12-31 | $1.98 Million | -42.94% |
| 1995-12-31 | $3.47 Million | -25.85% |
| 1994-12-31 | $4.68 Million | -- |